ETON PHARMACEUTICALS INC (ETON) Stock Income Statement
NASDAQ:ETON - Nasdaq - US29772L1089 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 48.33M | 39.01M | 31.64M | 21.25M | 21.83M | |||
| Cost Of Goods | 20.06M | 15.60M | 10.58M | 6.93M | 2.83M | |||
| Gross Profit | 28.27M | 23.41M | 21.06M | 14.32M | 19.01M | |||
| Operating Expenses | 30.11M | 25.59M | 22.25M | 23.07M | 20.50M | |||
| Research and Development | 4.66M | 3.25M | 3.32M | 4.48M | 6.24M | |||
| Selling, General, and Administrative Expenses | 26.35M | 22.34M | 18.93M | 18.58M | 14.27M | |||
| Operating Income | -1.86M | -2.18M | -1.19M | -8.75M | -1.50M | |||
| Interest Income/Expense | -2.23M | -1.21M | 503.00K | -760.00K | -1.01M | |||
| Other Income/Expense | N/A | N/A | N/A | 490.00K | N/A | |||
| Non Recurring Items | N/A | -415.00K | N/A | 0.00 | 370.00K | |||
| Income Before Taxes | -4.50M | -3.81M | -689.00K | -9.02M | -1.96M | |||
| Income Tax | 85.00K | 15.00K | 247.00K | 0.00 | 0.00 | |||
| Net Income | -4.58M | -3.82M | -936.00K | -9.02M | -1.96M | |||
| EBITDA | 52.00K | -1.04M | -291.00K | -6.98M | -1.04M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.18 | -0.15 | -0.04 | -0.36 | -0.08 | |||
| Non GAAP EPS | -0.04 | -0.14 | -0.06 | -0.35 | -0.11 | |||
| Statistics | ||||||||
| Gross Profit Margin | 58.49% | 60.01% | 66.56% | 67.39% | 87.08% | |||
| Profit Margin | -9.48% | -9.80% | -2.96% | -42.45% | -8.98% | |||
| Operating Profit Margin | -3.84% | -5.59% | -3.77% | -41.18% | -6.87% | |||
All data in USD